World Orphan Drug Congress USA

Improve your Probability of Success, visit Quintiles at booth #41.

Washington, D.C., USA (Washington Hilton)

April 20, 2016  -  April 22, 2016

Register Save to Calendar


Transforming the lives of patients and their families

Quintiles helps identify and address the complex challenges of rare disease studies by bringing together a specialized team with rare disease experience with tailored patient-centric approaches to global study planning and execution in order to speed treatments to market.

While at the conference, we hope you’ll stop by our booth (#41), or attend one of our round table sessions:

  • April 21 (1:50 PM -2:30 PM): Eric Gemmen, Senior Director of Epidemiology, will discuss “Implementing effective rare disease registries and how they contribute to the development of new therapies”
  • April 22 (11:40 AM-12:20 PM): Stella Blackburn, Vice President of Risk Management, will discuss “Using registries throughout the product lifecycle”

World Orphan Drug Congress USA is packed with great content exploring clinical development, patient partnerships, regulatory approval, reimbursement, exploiting global trends, manufacturing, distribution, orphan drug business models and commercialization strategies. We’re looking forward to seeing you there, and if you’d like to schedule a meeting with one of our Quintiles experts, email us at